SEC Form 4 · accession 0001596783-16-000093
Catalent, Inc. · CTLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wetteny Joseph
Officer — President - CSS
Period of report
Jul 26, 2016
Accepted (ET)
Jul 28, 2016 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596783
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 26, 2016 | A | 2,783 | $0.00 | A | 9,049 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF3 | $24.44 | Jul 26, 2016 | A | 14,266 | A | — | Jul 26, 2026 | Common Stock | 14,266 | 14,266 | D |
Explanation of responses
- F1The restricted stock units and options received by the reporting person were granted as part of the Issuer's annual long-term incentive plan to its executive officers and other personnel and were approved by the Issuer on July 26, 2016.
- F2Includes restricted stock units.
- F3On July 26, 2016, the reporting person was granted options to purchase 14,266 shares of common stock of the Issuer which vest and become exercisable in four equal installments beginning July 26, 2017.
Remarks
President - Clinical Supply Services